Low-dose radiation (LDR) induces hormesis and adaptive response in normal cells but not in cancer cells, suggesting its potential protection of normal tissue against damage induced by conventional radiotherapy. However, the underlying mechanisms are not well established. We addressed this in the present study by examining the role of the ataxia telangiectasia mutated (ATM) signaling pathway in response to LDR using A549 human lung adenocarcinoma cells and HBE135-E6E7 (HBE) normal lung epithelial cells. We found that LDR-activated ATM was the initiating event in hormesis and adaptive response to LDR in HBE cells. ATM activation increased the expression of CDK4/CDK6/cyclin D1 by activating the AKT/glycogen synthase kinase (GSK)-3 beta signaling pathway, which stimulated HBE cell proliferation. Activation of ATM/AKT/GSK-3 beta signaling also increased nuclear accumulation of nuclear factor erythroid 2-related factor 2, leading to increased expression of antioxidants, which mitigated cellular damage from excessive reactive oxygen species production induced by high-dose radiation. However, these effects were not observed in A549 cells. Thus, the failure to activate these pathways in A549 cells likely explains the difference between normal and cancer cells in terms of hormesis and adaptive response to LDR.
[1]Jilin Univ, Hosp 1, Canc Ctr, Changchun 130021, Peoples R China.
[2]Jilin Univ, Hosp 1, Dept Radiat Oncol, Changchun 130021, Peoples R China.
[3]Univ Louisville, Dept Pediat, Kosair Childrens Hosp Res Inst, Louisville, KY 40292 USA.
[4]Univ Louisville, Dept Radiat Oncol, Kosair Childrens Hosp Res Inst, Louisville, KY 40292 USA.
[5]Univ Louisville, Dept Pharmacol, Kosair Childrens Hosp Res Inst, Louisville, KY 40292 USA.
[6]Univ Louisville, Dept Toxicol, Kosair Childrens Hosp Res Inst, Louisville, KY 40292 USA.
(8.0+极速模式)